These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9646644)

  • 1. Skeletal scintigraphy in breast cancer management.
    Bares R
    Q J Nucl Med; 1998 Mar; 42(1):43-8. PubMed ID: 9646644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between conventional imaging (abdominal-pelvic computed tomography and bone scan) and [(18)F]choline positron emission tomography/computed tomography imaging for the initial staging of patients with intermediate- tohigh-risk prostate cancer: A retrospective analysis.
    Evangelista L; Cimitan M; Zattoni F; Guttilla A; Zattoni F; Saladini G
    Scand J Urol; 2015; 49(5):345-53. PubMed ID: 25649494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The semiquantitative bone scintigraphy index correlates with serum tartrate-resistant acid phosphatase activity in breast cancer patients with bone metastasis.
    Tsai SH; Chen CY; Ku CH; Janckila AJ; Yam LT; Yu JC; Chuang KW; Chao TY
    Mayo Clin Proc; 2007 Aug; 82(8):917-26. PubMed ID: 17673059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of malignant skeletal disease: initial experience with 18F-fluoride PET/CT and comparison between 18F-fluoride PET and 18F-fluoride PET/CT.
    Even-Sapir E; Metser U; Flusser G; Zuriel L; Kollender Y; Lerman H; Lievshitz G; Ron I; Mishani E
    J Nucl Med; 2004 Feb; 45(2):272-8. PubMed ID: 14960647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of MRI in comparison to scintigraphy, PET, MS-CT and PET/CT for the detection of metastases of bone.
    Ghanem N; Uhl M; Brink I; Schäfer O; Kelly T; Moser E; Langer M
    Eur J Radiol; 2005 Jul; 55(1):41-55. PubMed ID: 15950100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.
    Even-Sapir E; Metser U; Mishani E; Lievshitz G; Lerman H; Leibovitch I
    J Nucl Med; 2006 Feb; 47(2):287-97. PubMed ID: 16455635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDG PET can replace bone scintigraphy in primary staging of malignant lymphoma.
    Moog F; Kotzerke J; Reske SN
    J Nucl Med; 1999 Sep; 40(9):1407-13. PubMed ID: 10492357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radiologic detection of metastatic bone tumors].
    Sugimoto E; Tamagawa M; Okawara K; Osawa T
    Gan No Rinsho; 1988 Aug; 34(10):1491-7. PubMed ID: 3172506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Whole-Body MRI, CT, and Bone Scintigraphy for Response Evaluation of Cancer Therapeutics in Metastatic Breast Cancer to Bone.
    Kosmin M; Padhani AR; Gogbashian A; Woolf D; Ah-See ML; Ostler P; Sutherland S; Miles D; Noble J; Koh DM; Marshall A; Dunn J; Makris A
    Radiology; 2020 Dec; 297(3):622-629. PubMed ID: 33078998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Skeletal scintigraphy in the care of breast cancer . Long-term follow-up over 8 years].
    Anger K; Möller T; Zeimantz E
    Strahlentherapie; 1983 Dec; 159(12):745-50. PubMed ID: 6665812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Staging non-small cell lung cancer with whole-body PET.
    Marom EM; McAdams HP; Erasmus JJ; Goodman PC; Culhane DK; Coleman RE; Herndon JE; Patz EF
    Radiology; 1999 Sep; 212(3):803-9. PubMed ID: 10478250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of the efficacy of bone scanning in prostate and breast cancer.
    O'Sullivan JM; Cook GJ
    Q J Nucl Med; 2002 Jun; 46(2):152-9. PubMed ID: 12114879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose.
    Shreve PD; Grossman HB; Gross MD; Wahl RL
    Radiology; 1996 Jun; 199(3):751-6. PubMed ID: 8638000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skeletal metastases from breast cancer: imaging with nuclear medicine.
    Cook GJ; Fogelman I
    Semin Nucl Med; 1999 Jan; 29(1):69-79. PubMed ID: 9990685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [What do clinicians do with the results of the systematic staging imaging at the time of the breast cancer diagnosis?].
    Turpin A; Mailliez A; Vennin P; Bonneterre J
    Gynecol Obstet Fertil; 2014 May; 42(5):325-30. PubMed ID: 24411340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fluoride-positron emission tomography/computed tomography for differential diagnosis in suspected bone metastasis].
    Petersen H; Ogren M; Høilund-Carlsen PF
    Ugeskr Laeger; 2010 May; 172(20):1538-9. PubMed ID: 20483103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of single-photon emission computed tomography/computed tomography in benign and malignant bone disease.
    Horger M; Bares R
    Semin Nucl Med; 2006 Oct; 36(4):286-94. PubMed ID: 16950146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bone scintigraphy in metastatic bone disease].
    Itoh K
    Kaku Igaku; 2000 Jan; 37(1):1-5. PubMed ID: 10714061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of whole-body fluorine-18-FDG PET for the detection of recurrent or metastatic breast carcinoma.
    Moon DH; Maddahi J; Silverman DH; Glaspy JA; Phelps ME; Hoh CK
    J Nucl Med; 1998 Mar; 39(3):431-5. PubMed ID: 9529287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A meta-analysis of ¹⁸FDG-PET-CT, ¹⁸FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with lung cancer.
    Qu X; Huang X; Yan W; Wu L; Dai K
    Eur J Radiol; 2012 May; 81(5):1007-15. PubMed ID: 21354739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.